ITGAL and type 1 diabetes mellitus: Clinical studies in patients with type 1 diabetes (T1D) have supported this finding, in which monocytes from T1D patients are activated [16], express higher levels of adhesion molecules such as integrins CD11a and CD11b [17, 18] and have greater potency to bind to endothelial cells [18].